DrugPatentWatch Database Preview
LUVOX CR Drug Profile
Email this page to a colleague
» See Plans and PricingWhen do Luvox Cr patents expire, and when can generic versions of Luvox Cr launch?
Luvox Cr is a drug marketed by Jazz Pharms and is included in one NDA. There is one patent protecting this drug and two Paragraph IV challenges.
This drug has twenty-four patent family members in eighteen countries.
The generic ingredient in LUVOX CR is fluvoxamine maleate. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the fluvoxamine maleate profile page.
US ANDA Litigation and Generic Entry Outlook for Luvox Cr
A generic version of LUVOX CR was approved as fluvoxamine maleate by UPSHER SMITH LABS on November 29th, 2000.
Summary for LUVOX CR
| International Patents: | 24 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 55 |
| Patent Applications: | 971 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | LUVOX CR at DailyMed |
Paragraph IV (Patent) Challenges for LUVOX CR
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| LUVOX CR | CAPSULE, EXTENDED RELEASE;ORAL | fluvoxamine maleate | 022033 | 2009-04-20 |
| LUVOX CR | CAPSULE, EXTENDED RELEASE;ORAL | fluvoxamine maleate | 022033 | 2009-04-13 |
US Patents and Regulatory Information for LUVOX CR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharms | LUVOX CR | fluvoxamine maleate | CAPSULE, EXTENDED RELEASE;ORAL | 022033-001 | Feb 28, 2008 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Jazz Pharms | LUVOX CR | fluvoxamine maleate | CAPSULE, EXTENDED RELEASE;ORAL | 022033-002 | Feb 28, 2008 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LUVOX CR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Jazz Pharms | LUVOX CR | fluvoxamine maleate | CAPSULE, EXTENDED RELEASE;ORAL | 022033-001 | Feb 28, 2008 | Start Trial | Start Trial |
| Jazz Pharms | LUVOX CR | fluvoxamine maleate | CAPSULE, EXTENDED RELEASE;ORAL | 022033-002 | Feb 28, 2008 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LUVOX CR
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 4426700 | Start Trial |
| Portugal | 1178780 | Start Trial |
| World Intellectual Property Organization (WIPO) | 0071099 | Start Trial |
| Hungary | 0201884 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
